Compare · MEC vs STE
MEC vs STE
Side-by-side comparison of Mayville Engineering Company Inc. (MEC) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- MEC operates in Industrials, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $24.74B, about 76.0x MEC ($325.4M).
- STE has been more active in the news (13 items in the past 4 weeks vs 5 for MEC).
- STE has more recent analyst coverage (18 ratings vs 11 for MEC).
- Company
- Mayville Engineering Company Inc.
- STERIS plc (Ireland)
- Price
- -
- -
- Market cap
- $325.4M
- $24.74B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 5
- 13
- Recent ratings
- 11
- 18
Mayville Engineering Company Inc.
Mayville Engineering Company, Inc., together with its subsidiaries, operates as a contract manufacturer that serves the heavy and medium duty commercial vehicle, construction and access equipment, powersports, agriculture, military, and other end markets in the United States. The company provides a range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components. It also supplies engineered components to original equipment manufacturers. The company was founded in 1945 and is headquartered in Mayville, Wisconsin.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest MEC
- Amendment: SEC Form SCHEDULE 13G/A filed by Mayville Engineering Company Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Mayville Engineering Company Inc.
- SEC Form 10-Q filed by Mayville Engineering Company Inc.
- Mayville Engineering Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Mayville Engineering Company Announces Third Quarter 2026 Results
- Mayville Engineering Company Announces Third Quarter 2026 Results Conference Call and Webcast Date
- Mayville Engineering Company Announces Strategic Footprint Expansion in the Southeastern U.S.
- SVP, GC & Secretary Leuba Sean P sold $327,031 worth of shares (12,855 units at $25.44), decreasing direct ownership by 66% to 6,633 units (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Mayville Engineering Company Inc.
- SEC Form 10-Q filed by Mayville Engineering Company Inc.
Latest STE
- Sr. VP and GM, Life Sciences Julia Madsen sold $531,960 worth of Ordinary Shares (2,046 units at $260.00), decreasing direct ownership by 17% to 10,211 units (SEC Form 4)
- Steris upgraded by Jefferies with a new price target
- Director Sohi Mohsen exercised 4,893 units of Ordinary Shares at a strike of $114.74 and sold $1,239,008 worth of Ordinary Shares (4,893 units at $253.22) (SEC Form 4)
- Sr. Vice Pres., CFO Burton Karen L exercised 5,880 units of Ordinary Shares at a strike of $147.05 and sold $1,503,046 worth of Ordinary Shares (5,880 units at $255.62) (SEC Form 4)
- STERIS plc (Ireland) filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 10-Q filed by STERIS plc (Ireland)
- STERIS plc (Ireland) filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- STERIS plc (Ireland) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits